Abstract
Since the development of antibody phage display, 20 years ago, this technique has been evolved to a valuable and robust tool for the development of recombinant human antibodies. Today, this technique is widely used for the generation of antibodies for therapy and basic research. Automation processes and decrease of costs will enable the highthroughput design of monoclonal binders against a huge number of different antigens, presenting a valuable tool for proteome research. This review presents an overview on phage display technology and antibody libraries. The benefit of recombinant antibodies for basic research, diagnostic and therapy is shown.
Keywords: phage display, scFv, antibody, proteome research, antibody gene library, monoclonal antibody, human antibody, Humira, antibody genes, Murine antibodies, B-lymphocytes from, IgGs, E. coli, phagemid, bacteriophage M13
Current Biotechnology
Title: Generating Recombinant Antibodies for Research, Diagnostics and Therapy Using Phage Display
Volume: 1 Issue: 1
Author(s): Andre Frenzel, David Frode, Torsten Meyer, Thomas Schirrmann and Michael Hust
Affiliation:
Keywords: phage display, scFv, antibody, proteome research, antibody gene library, monoclonal antibody, human antibody, Humira, antibody genes, Murine antibodies, B-lymphocytes from, IgGs, E. coli, phagemid, bacteriophage M13
Abstract: Since the development of antibody phage display, 20 years ago, this technique has been evolved to a valuable and robust tool for the development of recombinant human antibodies. Today, this technique is widely used for the generation of antibodies for therapy and basic research. Automation processes and decrease of costs will enable the highthroughput design of monoclonal binders against a huge number of different antigens, presenting a valuable tool for proteome research. This review presents an overview on phage display technology and antibody libraries. The benefit of recombinant antibodies for basic research, diagnostic and therapy is shown.
Export Options
About this article
Cite this article as:
Frenzel Andre, Frode David, Meyer Torsten, Schirrmann Thomas and Hust Michael, Generating Recombinant Antibodies for Research, Diagnostics and Therapy Using Phage Display, Current Biotechnology 2012; 1 (1) . https://dx.doi.org/10.2174/2211550111201010033
DOI https://dx.doi.org/10.2174/2211550111201010033 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Role of Lipopolysaccharides in Potential Applications of Nanocarrier Systems
Current Pharmaceutical Design Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Drug Target Identification for Neuronal Apoptosis Through a Genome Scale Screening
Current Medicinal Chemistry Discovery, SAR and Medicinal Chemistry of Herpesvirus Helicase Primase Inhibitors
Current Medicinal Chemistry - Anti-Infective Agents Peptide Based Viral Detection Systems for Effective Diagnosis of Common Viral Infections in India
Current Protein & Peptide Science Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review
Current Medicinal Chemistry Glycine Rich P-loop Motif in Deoxyuridine Pyrophosphatase
Current Protein & Peptide Science Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Vitamin D Analogs- Drug Design Based on Proteins Involved in Vitamin D Signal Transduction
Current Drug Targets - Immune, Endocrine & Metabolic Disorders mGluRI Targets Microglial Activation and Selectively Prevents Neuronal Cell Engulfment Through Akt and Caspase Dependent Pathways
Current Neurovascular Research Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets West Nile Virus Vaccine.
Current Drug Targets - Infectious Disorders The Endocannabinoid System and Multiple Sclerosis
Current Pharmaceutical Design Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets